nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.053	0.139	CbGbCtD
Paliperidone—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0426	0.111	CbGbCtD
Paliperidone—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0402	0.105	CbGbCtD
Paliperidone—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.037	0.0968	CbGbCtD
Paliperidone—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0273	0.0713	CbGbCtD
Paliperidone—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0265	0.0692	CbGbCtD
Paliperidone—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0246	0.0644	CbGbCtD
Paliperidone—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0207	0.0541	CbGbCtD
Paliperidone—CYP3A4—Betamethasone—rheumatoid arthritis	0.0177	0.0464	CbGbCtD
Paliperidone—CYP3A4—Prednisolone—rheumatoid arthritis	0.0175	0.0458	CbGbCtD
Paliperidone—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0166	0.0434	CbGbCtD
Paliperidone—CYP3A4—Prednisone—rheumatoid arthritis	0.0165	0.0432	CbGbCtD
Paliperidone—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0162	0.0424	CbGbCtD
Paliperidone—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0157	0.041	CbGbCtD
Paliperidone—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0103	0.027	CbGbCtD
Paliperidone—Discomfort—Betamethasone—rheumatoid arthritis	0.000209	0.000502	CcSEcCtD
Paliperidone—Discomfort—Dexamethasone—rheumatoid arthritis	0.000209	0.000502	CcSEcCtD
Paliperidone—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000209	0.000502	CcSEcCtD
Paliperidone—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000208	0.000501	CcSEcCtD
Paliperidone—Pain—Prednisolone—rheumatoid arthritis	0.000207	0.000499	CcSEcCtD
Paliperidone—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000206	0.000496	CcSEcCtD
Paliperidone—Nausea—Leflunomide—rheumatoid arthritis	0.000205	0.000494	CcSEcCtD
Paliperidone—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000205	0.000493	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000205	0.000492	CcSEcCtD
Paliperidone—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000204	0.000492	CcSEcCtD
Paliperidone—Vision blurred—Prednisone—rheumatoid arthritis	0.000204	0.00049	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000203	0.000489	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000203	0.000489	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000203	0.000488	CcSEcCtD
Paliperidone—Pain—Hydrocortisone—rheumatoid arthritis	0.000203	0.000488	CcSEcCtD
Paliperidone—Oedema—Betamethasone—rheumatoid arthritis	0.000202	0.000487	CcSEcCtD
Paliperidone—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000202	0.000487	CcSEcCtD
Paliperidone—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000202	0.000487	CcSEcCtD
Paliperidone—Oedema—Dexamethasone—rheumatoid arthritis	0.000202	0.000487	CcSEcCtD
Paliperidone—Insomnia—Triamcinolone—rheumatoid arthritis	0.000202	0.000486	CcSEcCtD
Paliperidone—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000201	0.000485	CcSEcCtD
Paliperidone—Infection—Dexamethasone—rheumatoid arthritis	0.000201	0.000484	CcSEcCtD
Paliperidone—Infection—Betamethasone—rheumatoid arthritis	0.000201	0.000484	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.0002	0.000482	CcSEcCtD
Paliperidone—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.0002	0.000482	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.0002	0.000481	CcSEcCtD
Paliperidone—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.0002	0.000481	CcSEcCtD
Paliperidone—Anaemia—Prednisone—rheumatoid arthritis	0.0002	0.00048	CcSEcCtD
Paliperidone—Shock—Dexamethasone—rheumatoid arthritis	0.000199	0.000479	CcSEcCtD
Paliperidone—Shock—Betamethasone—rheumatoid arthritis	0.000199	0.000479	CcSEcCtD
Paliperidone—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000199	0.000479	CcSEcCtD
Paliperidone—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000199	0.000478	CcSEcCtD
Paliperidone—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000199	0.000478	CcSEcCtD
Paliperidone—Agitation—Prednisone—rheumatoid arthritis	0.000199	0.000478	CcSEcCtD
Paliperidone—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000198	0.000477	CcSEcCtD
Paliperidone—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000198	0.000477	CcSEcCtD
Paliperidone—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000198	0.000475	CcSEcCtD
Paliperidone—Tachycardia—Betamethasone—rheumatoid arthritis	0.000198	0.000475	CcSEcCtD
Paliperidone—Angioedema—Prednisone—rheumatoid arthritis	0.000197	0.000475	CcSEcCtD
Paliperidone—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000196	0.000473	CcSEcCtD
Paliperidone—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000196	0.000473	CcSEcCtD
Paliperidone—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000196	0.000472	CcSEcCtD
Paliperidone—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000195	0.00047	CcSEcCtD
Paliperidone—Malaise—Prednisone—rheumatoid arthritis	0.000195	0.000469	CcSEcCtD
Paliperidone—Vertigo—Prednisone—rheumatoid arthritis	0.000194	0.000467	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—rheumatoid arthritis	0.000194	0.000466	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000194	0.000466	CcSEcCtD
Paliperidone—Syncope—Prednisone—rheumatoid arthritis	0.000194	0.000466	CcSEcCtD
Paliperidone—Tinnitus—Methotrexate—rheumatoid arthritis	0.000193	0.000465	CcSEcCtD
Paliperidone—Anorexia—Dexamethasone—rheumatoid arthritis	0.000193	0.000464	CcSEcCtD
Paliperidone—Anorexia—Betamethasone—rheumatoid arthritis	0.000193	0.000464	CcSEcCtD
Paliperidone—Urticaria—Prednisolone—rheumatoid arthritis	0.000193	0.000464	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000192	0.000463	CcSEcCtD
Paliperidone—Fatigue—Triamcinolone—rheumatoid arthritis	0.000192	0.000463	CcSEcCtD
Paliperidone—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000192	0.000462	CcSEcCtD
Paliperidone—Asthenia—Cyclosporine—rheumatoid arthritis	0.000191	0.00046	CcSEcCtD
Paliperidone—Pain—Triamcinolone—rheumatoid arthritis	0.000191	0.000459	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—rheumatoid arthritis	0.00019	0.000457	CcSEcCtD
Paliperidone—Hypotension—Dexamethasone—rheumatoid arthritis	0.000189	0.000455	CcSEcCtD
Paliperidone—Hypotension—Betamethasone—rheumatoid arthritis	0.000189	0.000455	CcSEcCtD
Paliperidone—Pruritus—Cyclosporine—rheumatoid arthritis	0.000189	0.000454	CcSEcCtD
Paliperidone—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000188	0.000453	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—rheumatoid arthritis	0.000188	0.000453	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000187	0.000451	CcSEcCtD
Paliperidone—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000187	0.000451	CcSEcCtD
Paliperidone—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000187	0.000451	CcSEcCtD
Paliperidone—Convulsion—Prednisone—rheumatoid arthritis	0.000187	0.00045	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000187	0.00045	CcSEcCtD
Paliperidone—Hypertension—Prednisone—rheumatoid arthritis	0.000186	0.000449	CcSEcCtD
Paliperidone—Chills—Methotrexate—rheumatoid arthritis	0.000186	0.000448	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000184	0.000444	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000184	0.000444	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—rheumatoid arthritis	0.000184	0.000443	CcSEcCtD
Paliperidone—Myalgia—Prednisone—rheumatoid arthritis	0.000184	0.000443	CcSEcCtD
Paliperidone—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000184	0.000442	CcSEcCtD
Paliperidone—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000183	0.000441	CcSEcCtD
Paliperidone—Anxiety—Prednisone—rheumatoid arthritis	0.000183	0.000441	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—rheumatoid arthritis	0.000183	0.000441	CcSEcCtD
Paliperidone—Insomnia—Dexamethasone—rheumatoid arthritis	0.000183	0.000441	CcSEcCtD
Paliperidone—Insomnia—Betamethasone—rheumatoid arthritis	0.000183	0.000441	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000183	0.00044	CcSEcCtD
Paliperidone—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000182	0.000439	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000182	0.000438	CcSEcCtD
Paliperidone—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000182	0.000437	CcSEcCtD
Paliperidone—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000182	0.000437	CcSEcCtD
Paliperidone—Discomfort—Prednisone—rheumatoid arthritis	0.000182	0.000437	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—rheumatoid arthritis	0.000182	0.000437	CcSEcCtD
Paliperidone—Erythema—Methotrexate—rheumatoid arthritis	0.000181	0.000434	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—rheumatoid arthritis	0.000181	0.000434	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000179	0.00043	CcSEcCtD
Paliperidone—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000178	0.000429	CcSEcCtD
Paliperidone—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000178	0.000429	CcSEcCtD
Paliperidone—Urticaria—Triamcinolone—rheumatoid arthritis	0.000177	0.000427	CcSEcCtD
Paliperidone—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000177	0.000426	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000177	0.000425	CcSEcCtD
Paliperidone—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Dizziness—Cyclosporine—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Oedema—Prednisone—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000176	0.000424	CcSEcCtD
Paliperidone—Infection—Prednisone—rheumatoid arthritis	0.000175	0.000422	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000175	0.000421	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000175	0.000421	CcSEcCtD
Paliperidone—Back pain—Methotrexate—rheumatoid arthritis	0.000175	0.00042	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000175	0.00042	CcSEcCtD
Paliperidone—Fatigue—Betamethasone—rheumatoid arthritis	0.000175	0.00042	CcSEcCtD
Paliperidone—Fatigue—Dexamethasone—rheumatoid arthritis	0.000175	0.00042	CcSEcCtD
Paliperidone—Shock—Prednisone—rheumatoid arthritis	0.000173	0.000417	CcSEcCtD
Paliperidone—Pain—Dexamethasone—rheumatoid arthritis	0.000173	0.000417	CcSEcCtD
Paliperidone—Pain—Betamethasone—rheumatoid arthritis	0.000173	0.000417	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000173	0.000416	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—rheumatoid arthritis	0.000172	0.000414	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—rheumatoid arthritis	0.000171	0.000412	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—rheumatoid arthritis	0.00017	0.000409	CcSEcCtD
Paliperidone—Asthenia—Hydrocortisone—rheumatoid arthritis	0.00017	0.000409	CcSEcCtD
Paliperidone—Vomiting—Cyclosporine—rheumatoid arthritis	0.00017	0.000408	CcSEcCtD
Paliperidone—Rash—Cyclosporine—rheumatoid arthritis	0.000168	0.000405	CcSEcCtD
Paliperidone—Anorexia—Prednisone—rheumatoid arthritis	0.000168	0.000404	CcSEcCtD
Paliperidone—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000168	0.000404	CcSEcCtD
Paliperidone—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000168	0.000403	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000167	0.000403	CcSEcCtD
Paliperidone—Headache—Cyclosporine—rheumatoid arthritis	0.000167	0.000402	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—rheumatoid arthritis	0.000167	0.000402	CcSEcCtD
Paliperidone—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000167	0.000401	CcSEcCtD
Paliperidone—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000167	0.000401	CcSEcCtD
Paliperidone—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000166	0.000398	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000166	0.000398	CcSEcCtD
Paliperidone—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000164	0.000396	CcSEcCtD
Paliperidone—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000164	0.000395	CcSEcCtD
Paliperidone—Malaise—Methotrexate—rheumatoid arthritis	0.000163	0.000392	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—rheumatoid arthritis	0.000162	0.00039	CcSEcCtD
Paliperidone—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000162	0.00039	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—rheumatoid arthritis	0.000162	0.000389	CcSEcCtD
Paliperidone—Urticaria—Dexamethasone—rheumatoid arthritis	0.000161	0.000387	CcSEcCtD
Paliperidone—Urticaria—Betamethasone—rheumatoid arthritis	0.000161	0.000387	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000161	0.000387	CcSEcCtD
Paliperidone—Dizziness—Prednisolone—rheumatoid arthritis	0.00016	0.000386	CcSEcCtD
Paliperidone—Asthenia—Triamcinolone—rheumatoid arthritis	0.00016	0.000385	CcSEcCtD
Paliperidone—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.00016	0.000385	CcSEcCtD
Paliperidone—Body temperature increased—Betamethasone—rheumatoid arthritis	0.00016	0.000385	CcSEcCtD
Paliperidone—Abdominal pain—Betamethasone—rheumatoid arthritis	0.00016	0.000385	CcSEcCtD
Paliperidone—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.00016	0.000385	CcSEcCtD
Paliperidone—Asthenia—Methylprednisolone—rheumatoid arthritis	0.00016	0.000384	CcSEcCtD
Paliperidone—Insomnia—Prednisone—rheumatoid arthritis	0.000159	0.000384	CcSEcCtD
Paliperidone—Nausea—Cyclosporine—rheumatoid arthritis	0.000158	0.000381	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—rheumatoid arthritis	0.000158	0.000381	CcSEcCtD
Paliperidone—Pruritus—Triamcinolone—rheumatoid arthritis	0.000158	0.00038	CcSEcCtD
Paliperidone—Cough—Methotrexate—rheumatoid arthritis	0.000158	0.000379	CcSEcCtD
Paliperidone—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000157	0.000379	CcSEcCtD
Paliperidone—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000157	0.000377	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—rheumatoid arthritis	0.000156	0.000376	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—rheumatoid arthritis	0.000155	0.000373	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—rheumatoid arthritis	0.000154	0.00037	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—rheumatoid arthritis	0.000154	0.00037	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—rheumatoid arthritis	0.000154	0.00037	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—rheumatoid arthritis	0.000153	0.000369	CcSEcCtD
Paliperidone—Rash—Prednisolone—rheumatoid arthritis	0.000153	0.000368	CcSEcCtD
Paliperidone—Dermatitis—Prednisolone—rheumatoid arthritis	0.000153	0.000368	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000153	0.000367	CcSEcCtD
Paliperidone—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000152	0.000367	CcSEcCtD
Paliperidone—Fatigue—Prednisone—rheumatoid arthritis	0.000152	0.000366	CcSEcCtD
Paliperidone—Headache—Prednisolone—rheumatoid arthritis	0.000152	0.000366	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—rheumatoid arthritis	0.000152	0.000365	CcSEcCtD
Paliperidone—Constipation—Prednisone—rheumatoid arthritis	0.000151	0.000363	CcSEcCtD
Paliperidone—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000151	0.000363	CcSEcCtD
Paliperidone—Rash—Hydrocortisone—rheumatoid arthritis	0.000149	0.00036	CcSEcCtD
Paliperidone—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000149	0.000359	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—rheumatoid arthritis	0.000149	0.000358	CcSEcCtD
Paliperidone—Headache—Hydrocortisone—rheumatoid arthritis	0.000148	0.000357	CcSEcCtD
Paliperidone—Dizziness—Triamcinolone—rheumatoid arthritis	0.000148	0.000355	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000147	0.000355	CcSEcCtD
Paliperidone—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000147	0.000354	CcSEcCtD
Paliperidone—Infection—Methotrexate—rheumatoid arthritis	0.000146	0.000352	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000145	0.00035	CcSEcCtD
Paliperidone—Asthenia—Betamethasone—rheumatoid arthritis	0.000145	0.00035	CcSEcCtD
Paliperidone—Asthenia—Dexamethasone—rheumatoid arthritis	0.000145	0.00035	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000144	0.000348	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000144	0.000347	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000144	0.000347	CcSEcCtD
Paliperidone—Nausea—Prednisolone—rheumatoid arthritis	0.000144	0.000347	CcSEcCtD
Paliperidone—Pruritus—Betamethasone—rheumatoid arthritis	0.000143	0.000345	CcSEcCtD
Paliperidone—Pruritus—Dexamethasone—rheumatoid arthritis	0.000143	0.000345	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—rheumatoid arthritis	0.000143	0.000344	CcSEcCtD
Paliperidone—Vomiting—Triamcinolone—rheumatoid arthritis	0.000142	0.000341	CcSEcCtD
Paliperidone—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000142	0.000341	CcSEcCtD
Paliperidone—Nausea—Hydrocortisone—rheumatoid arthritis	0.000141	0.000339	CcSEcCtD
Paliperidone—Rash—Triamcinolone—rheumatoid arthritis	0.000141	0.000339	CcSEcCtD
Paliperidone—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000141	0.000338	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—rheumatoid arthritis	0.00014	0.000338	CcSEcCtD
Paliperidone—Rash—Methylprednisolone—rheumatoid arthritis	0.00014	0.000338	CcSEcCtD
Paliperidone—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00014	0.000337	CcSEcCtD
Paliperidone—Urticaria—Prednisone—rheumatoid arthritis	0.00014	0.000337	CcSEcCtD
Paliperidone—Headache—Triamcinolone—rheumatoid arthritis	0.00014	0.000336	CcSEcCtD
Paliperidone—Headache—Methylprednisolone—rheumatoid arthritis	0.000139	0.000336	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—rheumatoid arthritis	0.000139	0.000335	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—rheumatoid arthritis	0.000139	0.000335	CcSEcCtD
Paliperidone—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000139	0.000333	CcSEcCtD
Paliperidone—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000139	0.000333	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—rheumatoid arthritis	0.000138	0.000331	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000134	0.000323	CcSEcCtD
Paliperidone—Dizziness—Dexamethasone—rheumatoid arthritis	0.000134	0.000322	CcSEcCtD
Paliperidone—Dizziness—Betamethasone—rheumatoid arthritis	0.000134	0.000322	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—rheumatoid arthritis	0.000133	0.000321	CcSEcCtD
Paliperidone—Nausea—Triamcinolone—rheumatoid arthritis	0.000133	0.000319	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000132	0.000318	CcSEcCtD
Paliperidone—Nausea—Methylprednisolone—rheumatoid arthritis	0.000132	0.000318	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000131	0.000316	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—rheumatoid arthritis	0.000131	0.000315	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—rheumatoid arthritis	0.00013	0.000313	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—rheumatoid arthritis	0.00013	0.000312	CcSEcCtD
Paliperidone—Vomiting—Betamethasone—rheumatoid arthritis	0.000129	0.00031	CcSEcCtD
Paliperidone—Vomiting—Dexamethasone—rheumatoid arthritis	0.000129	0.00031	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000128	0.000308	CcSEcCtD
Paliperidone—Rash—Dexamethasone—rheumatoid arthritis	0.000128	0.000307	CcSEcCtD
Paliperidone—Rash—Betamethasone—rheumatoid arthritis	0.000128	0.000307	CcSEcCtD
Paliperidone—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000128	0.000307	CcSEcCtD
Paliperidone—Dermatitis—Betamethasone—rheumatoid arthritis	0.000128	0.000307	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000127	0.000306	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—rheumatoid arthritis	0.000127	0.000306	CcSEcCtD
Paliperidone—Headache—Dexamethasone—rheumatoid arthritis	0.000127	0.000305	CcSEcCtD
Paliperidone—Headache—Betamethasone—rheumatoid arthritis	0.000127	0.000305	CcSEcCtD
Paliperidone—Asthenia—Prednisone—rheumatoid arthritis	0.000126	0.000304	CcSEcCtD
Paliperidone—Pain—Methotrexate—rheumatoid arthritis	0.000126	0.000303	CcSEcCtD
Paliperidone—Pruritus—Prednisone—rheumatoid arthritis	0.000125	0.0003	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000121	0.000292	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—rheumatoid arthritis	0.000121	0.00029	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.00012	0.00029	CcSEcCtD
Paliperidone—Nausea—Betamethasone—rheumatoid arthritis	0.00012	0.000289	CcSEcCtD
Paliperidone—Nausea—Dexamethasone—rheumatoid arthritis	0.00012	0.000289	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—rheumatoid arthritis	0.000117	0.000282	CcSEcCtD
Paliperidone—Dizziness—Prednisone—rheumatoid arthritis	0.000117	0.000281	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000116	0.00028	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000116	0.00028	CcSEcCtD
Paliperidone—Vomiting—Prednisone—rheumatoid arthritis	0.000112	0.00027	CcSEcCtD
Paliperidone—Rash—Prednisone—rheumatoid arthritis	0.000111	0.000268	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—rheumatoid arthritis	0.000111	0.000267	CcSEcCtD
Paliperidone—Headache—Prednisone—rheumatoid arthritis	0.00011	0.000266	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000109	0.000261	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—rheumatoid arthritis	0.000106	0.000254	CcSEcCtD
Paliperidone—Nausea—Prednisone—rheumatoid arthritis	0.000105	0.000252	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—rheumatoid arthritis	0.000104	0.000251	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000101	0.000243	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—rheumatoid arthritis	9.74e-05	0.000234	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—rheumatoid arthritis	9.37e-05	0.000225	CcSEcCtD
Paliperidone—Rash—Methotrexate—rheumatoid arthritis	9.29e-05	0.000224	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—rheumatoid arthritis	9.28e-05	0.000223	CcSEcCtD
Paliperidone—Headache—Methotrexate—rheumatoid arthritis	9.23e-05	0.000222	CcSEcCtD
Paliperidone—Nausea—Methotrexate—rheumatoid arthritis	8.75e-05	0.000211	CcSEcCtD
Paliperidone—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	1.33e-05	6.57e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TYK2—rheumatoid arthritis	1.33e-05	6.56e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	1.32e-05	6.55e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.32e-05	6.53e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NOS3—rheumatoid arthritis	1.32e-05	6.52e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	1.32e-05	6.52e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	1.31e-05	6.5e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	1.31e-05	6.49e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1.31e-05	6.47e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.31e-05	6.47e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—LEP—rheumatoid arthritis	1.3e-05	6.45e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CD80—rheumatoid arthritis	1.3e-05	6.45e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NOS3—rheumatoid arthritis	1.3e-05	6.44e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—POMC—rheumatoid arthritis	1.3e-05	6.43e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCL8—rheumatoid arthritis	1.3e-05	6.43e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	1.29e-05	6.4e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.29e-05	6.38e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2—rheumatoid arthritis	1.29e-05	6.38e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—rheumatoid arthritis	1.28e-05	6.34e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	1.28e-05	6.33e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.28e-05	6.33e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	1.28e-05	6.32e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL2—rheumatoid arthritis	1.27e-05	6.29e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6R—rheumatoid arthritis	1.27e-05	6.27e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.27e-05	6.26e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2—rheumatoid arthritis	1.26e-05	6.24e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.26e-05	6.24e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	1.26e-05	6.22e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—rheumatoid arthritis	1.26e-05	6.21e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	1.25e-05	6.2e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.25e-05	6.18e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2—rheumatoid arthritis	1.24e-05	6.14e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—POMC—rheumatoid arthritis	1.24e-05	6.13e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—rheumatoid arthritis	1.24e-05	6.11e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	1.23e-05	6.1e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.23e-05	6.09e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—FN1—rheumatoid arthritis	1.23e-05	6.09e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.23e-05	6.08e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.23e-05	6.07e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.23e-05	6.06e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—POMC—rheumatoid arthritis	1.22e-05	6.05e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MMP9—rheumatoid arthritis	1.22e-05	6.03e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL2—rheumatoid arthritis	1.21e-05	5.99e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6R—rheumatoid arthritis	1.21e-05	5.98e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	1.21e-05	5.97e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NFKB1—rheumatoid arthritis	1.21e-05	5.97e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.2e-05	5.95e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	1.2e-05	5.94e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	1.2e-05	5.94e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	1.2e-05	5.92e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MMP9—rheumatoid arthritis	1.19e-05	5.91e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.19e-05	5.9e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	1.19e-05	5.89e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MAPK8—rheumatoid arthritis	1.19e-05	5.87e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	1.18e-05	5.85e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.18e-05	5.85e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CD80—rheumatoid arthritis	1.18e-05	5.84e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MMP9—rheumatoid arthritis	1.17e-05	5.81e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	1.17e-05	5.81e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.17e-05	5.79e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NFKB1—rheumatoid arthritis	1.16e-05	5.75e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.16e-05	5.75e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	1.16e-05	5.73e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TYK2—rheumatoid arthritis	1.15e-05	5.72e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL8—rheumatoid arthritis	1.15e-05	5.71e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.15e-05	5.69e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MAPK8—rheumatoid arthritis	1.14e-05	5.65e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	1.14e-05	5.65e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	1.13e-05	5.61e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.13e-05	5.58e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.12e-05	5.56e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	1.12e-05	5.55e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—POMC—rheumatoid arthritis	1.12e-05	5.55e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.12e-05	5.54e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	1.12e-05	5.53e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.12e-05	5.53e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.12e-05	5.53e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	1.12e-05	5.53e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—rheumatoid arthritis	1.11e-05	5.51e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	1.11e-05	5.51e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	1.11e-05	5.5e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	1.1e-05	5.46e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	1.1e-05	5.44e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	1.1e-05	5.44e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.1e-05	5.44e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	1.1e-05	5.43e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.1e-05	5.43e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	1.1e-05	5.43e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.1e-05	5.42e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	1.09e-05	5.42e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	1.09e-05	5.41e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.08e-05	5.36e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	1.08e-05	5.34e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	1.08e-05	5.32e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	1.08e-05	5.32e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	1.07e-05	5.31e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.07e-05	5.31e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	1.07e-05	5.27e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	1.06e-05	5.23e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—VEGFA—rheumatoid arthritis	1.06e-05	5.22e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.05e-05	5.18e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	1.04e-05	5.16e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.04e-05	5.15e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.03e-05	5.11e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.03e-05	5.09e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	1.02e-05	5.06e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.02e-05	5.05e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.01e-05	5.02e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	1.01e-05	5.02e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.01e-05	4.98e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	1e-05	4.97e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1e-05	4.95e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	1e-05	4.95e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	9.98e-06	4.94e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	9.97e-06	4.93e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	9.96e-06	4.93e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	9.96e-06	4.93e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	9.96e-06	4.93e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	9.95e-06	4.93e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	9.91e-06	4.9e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—rheumatoid arthritis	9.84e-06	4.87e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	9.79e-06	4.85e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	9.77e-06	4.84e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	9.77e-06	4.83e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	9.76e-06	4.83e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	9.75e-06	4.82e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	9.73e-06	4.81e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—rheumatoid arthritis	9.68e-06	4.79e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	9.61e-06	4.76e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	9.59e-06	4.75e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	9.58e-06	4.74e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	9.56e-06	4.73e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	9.56e-06	4.73e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	9.51e-06	4.71e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	9.5e-06	4.7e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	9.42e-06	4.66e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	9.37e-06	4.64e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	9.32e-06	4.61e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	9.3e-06	4.6e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	9.25e-06	4.58e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	9.16e-06	4.53e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	9.15e-06	4.53e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	9.11e-06	4.51e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	9.1e-06	4.5e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	9.08e-06	4.49e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	9.05e-06	4.48e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	9e-06	4.45e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	8.95e-06	4.43e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	8.93e-06	4.42e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	8.91e-06	4.41e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	8.85e-06	4.38e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	8.83e-06	4.37e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	8.8e-06	4.36e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	8.8e-06	4.35e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	8.72e-06	4.31e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	8.71e-06	4.31e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	8.69e-06	4.3e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	8.67e-06	4.29e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	8.66e-06	4.29e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	8.6e-06	4.26e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	8.57e-06	4.24e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	8.56e-06	4.24e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	8.51e-06	4.21e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	8.46e-06	4.19e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	8.44e-06	4.18e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	8.42e-06	4.17e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	8.4e-06	4.15e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	8.3e-06	4.11e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	8.28e-06	4.1e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	8.27e-06	4.09e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	8.26e-06	4.09e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	8.24e-06	4.08e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	8.17e-06	4.04e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	8.13e-06	4.02e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	8.13e-06	4.02e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—rheumatoid arthritis	8.1e-06	4.01e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	8.09e-06	4e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	7.99e-06	3.95e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—rheumatoid arthritis	7.97e-06	3.94e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—rheumatoid arthritis	7.96e-06	3.94e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	7.9e-06	3.91e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	7.9e-06	3.91e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	7.9e-06	3.91e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	7.86e-06	3.89e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	7.84e-06	3.88e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAT—rheumatoid arthritis	7.8e-06	3.86e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	7.78e-06	3.85e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	7.77e-06	3.85e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	7.77e-06	3.84e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	7.77e-06	3.84e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	7.76e-06	3.84e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	7.69e-06	3.81e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	7.64e-06	3.78e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	7.63e-06	3.77e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	7.61e-06	3.77e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	7.57e-06	3.75e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	7.55e-06	3.74e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	7.52e-06	3.72e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.5e-06	3.71e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	7.48e-06	3.7e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	7.46e-06	3.69e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—rheumatoid arthritis	7.42e-06	3.67e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—rheumatoid arthritis	7.3e-06	3.61e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—rheumatoid arthritis	7.26e-06	3.59e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	7.25e-06	3.59e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	7.18e-06	3.55e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	7.17e-06	3.55e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	7.15e-06	3.54e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	7.14e-06	3.53e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	7.08e-06	3.5e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	7.07e-06	3.5e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	7.06e-06	3.49e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	7.04e-06	3.48e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	6.95e-06	3.44e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	6.94e-06	3.44e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	6.91e-06	3.42e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	6.58e-06	3.26e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	6.57e-06	3.25e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	6.51e-06	3.22e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	6.48e-06	3.21e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	6.48e-06	3.2e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	6.46e-06	3.2e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	6.42e-06	3.18e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	6.39e-06	3.16e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	6.35e-06	3.14e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	6.34e-06	3.14e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	6.17e-06	3.05e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	6.14e-06	3.04e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	5.97e-06	2.95e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	5.89e-06	2.92e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	5.88e-06	2.91e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	5.85e-06	2.9e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	5.65e-06	2.8e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	5.62e-06	2.78e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	5.47e-06	2.7e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	5.42e-06	2.68e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	5.38e-06	2.66e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	5.33e-06	2.64e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	5.32e-06	2.63e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	5.22e-06	2.58e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—rheumatoid arthritis	5.21e-06	2.58e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	4.96e-06	2.45e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	4.88e-06	2.41e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	4.87e-06	2.41e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	4.85e-06	2.4e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	4.78e-06	2.36e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—rheumatoid arthritis	4.75e-06	2.35e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	4.54e-06	2.25e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	4.44e-06	2.2e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	4.15e-06	2.05e-05	CbGpPWpGaD
